Cibc Private Wealth Group, LLC Intellia Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,671 shares of NTLA stock, worth $56,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,671
Previous 4,611
1.3%
Holding current value
$56,986
Previous $53,000
37.74%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NTLA
# of Institutions
340Shares Held
97MCall Options Held
1.66MPut Options Held
1.05M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$159 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$117 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$50.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$49.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $927M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...